Save 20% on Press Releases and More with NNW Prime! Click to View Details
WednesdayJun 17, 2026 11:57 am

NetworkNewsBreaks – ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Appoints Operations Director for Montauban Project 

This article has been disseminated on behalf of ESGold Corp. and may include paid advertising.  ESGold (CSE: ESAU) (OTCQB: ESAUF) announced the appointment of Pierre-Marc Gagnon, P.Eng., as operations director for its Montauban Gold-Silver Project in Québec. Gagnon brings experience spanning underground and open-pit mining, exploration, drilling and project development, including operational roles with companies such as Agnico Eagle Mines, Newmont and G.E.T.T. Gold. In his new role, he will support site execution, contractor coordination, technical planning and operational readiness as ESGold advances the fully permitted Montauban Project toward construction and future production. The company said the appointment reflects its continued focus on strengthening its Québec-based operations team while advancing construction and site preparation activities…

Continue Reading

WednesdayJun 17, 2026 11:41 am

NetworkNewsBreaks – VolitionRx (NYSE American: VNRX) Collaborates with Sysmex to Advance Nu.Q® NETs Assay Development 

VolitionRx Limited (NYSE American: VNRX) announced a collaboration with Sysmex (TYO: 6869) to optimize Volition's Nu.Q® NETs H3.1 assay on the Sysmex diagnostic platform. The agreement supports Volition's strategy of licensing its proprietary Nu.Q® NETs technology to established global diagnostics companies that can leverage their disease expertise, regulatory capabilities and installed analyzer base to accelerate development and commercialization. Volition said the collaboration has progressed beyond assay transfer and into the optimization phase for diseases associated with NETosis, a process implicated in conditions including sepsis and other acute and chronic diseases. The company believes the Nu.Q® NETs assay could provide improved diagnostic information, support patient monitoring and address a commercial opportunity with an estimated total addressable market of $3.8…

Continue Reading

WednesdayJun 17, 2026 11:24 am

NetworkNewsBreaks – IBN.Ai Celebrates 20 Years of Growth, Expands AI-Powered Communications Platform 

IBN.Ai, the corporate communications and digital engagement platform developed by IBN, is marking the company's 20th anniversary by highlighting two decades of growth, innovation and service to the investment community while advancing a new phase centered on artificial intelligence. Over the past 20 years, IBN has evolved into a multifaceted communications organization supported by a Dynamic Brand Portfolio of more than 75 investor-facing brands, relationships with more than 5,000 syndication partners and a social media network reaching millions of followers and subscribers. As it enters its next chapter, IBN is expanding its AI-focused ecosystem through brands including IBN.Ai, AINewsWire, InvestorBrand, Investor Intelligence Artificial…

Continue Reading

WednesdayJun 17, 2026 11:16 am

NetworkNewsBreaks – SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) Expands Ukraine Strategy with CFC Defence Engagement 

This article has been disseminated on behalf of SPARC AI Inc.  and may include paid advertising.  SPARC AI (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) announced it has engaged Ukraine-based CFC Defence to lead the company's market-entry and strategic-engagement program across Ukraine's defense ecosystem. The move advances SPARC AI's efforts to deploy its Overwatch GPS-denied navigation and targeting platform, following a series of recently announced milestones including agreements with Ukrainian drone manufacturers, the appointment of a local sales agent, expansion of business development and engineering teams, legal support arrangements and plans to establish a physical office in Ukraine. Under the agreement, CFC Defence will help identify and engage key Ukrainian military, government…

Continue Reading

WednesdayJun 17, 2026 10:32 am

NetworkNewsBreaks – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) (WKN: A3EKSZ) Completes AI and Quantum Computing Pilot for PNKP Inhibitor Program 

This article has been disseminated on behalf of Onco-Innovations Limited and may include paid advertising.  Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) (WKN: A3EKSZ) announced the successful completion of a pilot project with Kuano Ltd. that supports advancement of the company's PNKP Inhibitor Technology (ONC010) through AI-enabled and quantum-based computational analysis. Kuano delivered molecular modeling and computational findings that strengthened Onco's understanding of how its PNKP inhibitor and related analogs may interact with the target, producing a refined structural hypothesis for PNKP inhibition and establishing a framework for structure-based optimization and future evaluation. The project also applied quantum-based computational methods to assess PNKP structural behavior and develop human PNKP structural models for follow-on…

Continue Reading

WednesdayJun 17, 2026 10:10 am

NetworkNewsBreaks – ParaZero Technologies Ltd. (NASDAQ: PRZO) Receives Additional DefendAir Order From Tier-1 Defense Customer

ParaZero Technologies (NASDAQ: PRZO) announced it has received an additional order for its DefendAir Net Pod system from a second business unit within a Tier-1 Israeli-based global defense company. The order is intended to support integration of the DefendAir Net Pod into the customer's autonomous ground-based Counter-UAS platform and includes dedicated engineering integration services from ParaZero. The company said its DefendAir Net Pod provides a non-explosive, net-based drone interception capability designed for environments where precision, mobility and reduced collateral damage are critical. According to ParaZero, the order reflects growing demand for autonomous Counter-UAS platforms and supports its broader strategy of…

Continue Reading

WednesdayJun 17, 2026 9:40 am

NetworkNewsBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Advances Robotics Deployment at SAPU Bio Sterile Manufacturing Facility 

Nightfood Holdings (OTCQB: NGTF), through its TechForce Robotics subsidiary, announced the advancement of Phase 2 objectives under its joint development collaboration with Oncotelic Therapeutics (OTCQB: OTLC), highlighted by the deployment of PUR-E, an autonomous clean room support robot, within SAPU Bio's OEB-5 sterile injectable cGMP facility. The deployment expands the initiative beyond Phase 1 materials logistics operations and into sterile manufacturing and clean room environments, where TechForce and Oncotelic are evaluating robotics, automation and AI-driven technologies to support regulated pharmaceutical workflows.  PUR-E joins TechForce's LIM-E autonomous GMP support robot at the SAPU Bio facility, where the systems are being used to assess opportunities in sterile manufacturing operations, electronic batch record processes…

Continue Reading

WednesdayJun 17, 2026 9:10 am

NetworkNewsBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Positioned to Benefit From Growing Demand for AI Infrastructure Automation

Nightfood Holdings (OTCQB: NGTF) operating through TechForce Robotics, is featured in a new AINewsWire editorial examining how the rapid expansion of artificial intelligence infrastructure is increasing demand for advanced automation, robotics and precision manufacturing solutions. The report highlights TechForce's recent partnership with Jiun Jiang ("JJ Enterprise") to advance AI infrastructure, semiconductor manufacturing automation and pharmaceutical robotics, positioning the company alongside major AI ecosystem participants including Super Micro Computer Inc. (NASDAQ: SMCI), Palantir Technologies Inc. (NASDAQ: PLTR), Applied Materials Inc. (NASDAQ: AMAT) and KLA Corporation (NASDAQ: KLAC). The editorial notes that growing investment in AI data centers, advanced semiconductor packaging and…

Continue Reading

WednesdayJun 17, 2026 9:00 am

NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Advances AI-Powered GMP Manufacturing Platform

Oncotelic Therapeutics (OTCQB: OTLC) announced the completion of key Phase 2 objectives in its manufacturing automation initiative with TechForce Robotics, advancing commercialization of an AI-powered good manufacturing practices manufacturing services platform at SAPU Bio, the company's 45%-owned sterile injectable cGMP manufacturing joint venture. The Phase 2 deployment expands the capabilities of Oncotelic's proprietary PDAOAI(TM) platform across sterile manufacturing operations, electronic batch records, GMP workflow execution, cleanroom monitoring and autonomous materials movement. The company said the integrated platform combines PDAOAI(TM) with TechForce's autonomous robotic systems to support intelligent pharmaceutical manufacturing and create potential opportunities in software licensing, automation deployment, manufacturing partnerships…

Continue Reading

TuesdayJun 16, 2026 2:15 pm

NetworkNewsBreaks – Space Exploration Technologies Corp. (NASDAQ: SPCX) (SpaceX) Surpasses Amazon in Market Value as Post-IPO Rally Accelerates

SpaceX (NASDAQ: SPCX) briefly surpassed Amazon.com in market capitalization on June 16 as investors continued piling into shares following the company's record-setting initial public offering, according to a Reuters report. Reuters reported that shares of Elon Musk's rocket, satellite and artificial intelligence company climbed as much as 10%, pushing its valuation above $2.7 trillion and, at one point, ahead of both Amazon and Microsoft among the world's most valuable companies. The surge was fueled in part by the launch of options trading in SpaceX shares and growing investor enthusiasm surrounding the company's expanding presence in space technology, communications and artificial intelligence. Reuters noted that analysts expect additional buying pressure as SpaceX is positioned…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000